Health Data Analytics Institute Announces an Advanced Suite of Predictors and a Series of Strategic Collaborations with Leading Healthcare Organizations

PRESS RELEASE

BOSTON, Mass. – March 3, 2020 – Health Data Analytics Institute (HDAI) — a startup focused on delivering insights that transform patient care — today introduced an application programming interface (API) that provides access to their platform for predicting clinical complications, avoidable hospital admissions, and other outcomes. HDAI is collaborating with Cleveland Clinic, Houston Methodist, and New England Baptist Hospital on separate projects aimed at measuring the impact of HDAI’s validated, predictive platform on clinical decision-making and patient outcomes.

With HDAI’s API, health systems and physician groups can use a full suite of validated predictors to help clinicians deliver better care by giving them individualized risk profiles of their patients in real-time. The risk models will also be provided to select academic researchers requiring tools to adjust for patient comorbidities and other characteristics, as well as to study outcomes over time.

“Our goal is to democratize access to artificial intelligence (AI) in healthcare, to make it available and as easy to use for as many organizations and individuals as possible,” said Nassib Chamoun, founder and CEO of Health Data Analytics Institute. “Over the last year, healthcare providers have dramatically increased their investment in deploying AI. We’re focused on helping these organizations scale quickly without taking on unnecessary work. Our API-accessible platform delivers a suite of risk predictors, developed using more than 100 billion de-identified patient encounters. Client teams can load recent clinical data for individual patients or defined populations into our models to generate detailed, real-time risk profiles that can support better clinical decisions and more appropriate resource allocation.”

HDAI is collaborating with a range of healthcare institutions and is in the process of recruiting additional organizations. Most recently, HDAI received funding from the Robert Wood Johnson Foundation to support a project to analyze current and future demand for long-term care and to develop an API for clinical and health services researchers. HDAI is also working with New England Baptist Hospital to study the effectiveness of surgical and nonsurgical options for spinal procedures; with Cleveland Clinic on using AI to match patients with the appropriate level of presurgical support; and with Houston Methodist on testing potential clinical applications that would utilize HDAI’s risk predictors.

“What’s compelling about HDAI — even beyond the high relevance and calibration of their models based on the breadth and depth of the underlying data — is their pragmatic focus on applying AI to help improve clinical practice today, not in a distant future,” said Philippe Amouyal, managing director at Invus, a lead investor in HDAI. “Our involvement with HDAI stems from our belief that their platform has the potential to become a fundamental analytics layer that improves care by providing a rigorous quantification of patient risk to inform clinical judgment.”

The announcement of HDAI’s API and strategic partnerships comes on the heels of recent news that the Centers for Medicare and Medicaid Services (CMS) selected HDAI as one of the 25 participants — out of more than 300 applicants — to advance to the second phase of the AI Health Outcomes Challenge. The Challenge is a national initiative to harness healthcare’s collective creativity to develop better ways of predicting and preventing unplanned admissions and complications. CMS is slated to announce the seven finalists in the Challenge in April. In addition, HDAI recently raised a Series B round in July 2019 to deploy and scale their predictive risk modeling platform. Leading investors include Invus, Harry McPike, and several other prominent individuals.

HDAI’s founder and CEO, Nassib Chamoun, is a serial entrepreneur who founded Aspect Medical Systems, which was later sold to Covidien and whose product remains the standard for measuring the effects of anesthesia during surgery. Collectively, the HDAI team has deployed healthcare technologies that have impacted the lives of millions of patients and published hundreds of evidence-based studies and abstracts related to the application of data science in health and medicine.

 

Chamoun spoke on a panel at HIMSS 2020 with Google Cloud and Nuance Communications. The focus of the HIMSS panel was: Reactions from the Field — Artificial Intelligence and Machine Learning.

###

 

Health Data Analytics Institute (HDAI) is an analytics company with a validated, predictive platform for measuring short- and long-term clinical risks. Our platform provides accurate healthcare predictors built on extensive underlying data assets unlocked by a sophisticated risk modeling methodology refined over 20 years. We work with progressive health systems, physician groups, and life sciences companies to support the development of effective and targeted treatments, the delivery of higher-quality patient care, and the provision of appropriate services for populations. For more information, please visit: HDAI.

 

The Invus Group (Invus) is an evergreen equity investment platform with more than $8 billion of capital and principal offices in New York, Paris, and Hong Kong. The firm partners with owner-managers who aspire to transform their industries. For more information, please visit: www.invus.com

 

Harry McPike has been actively trading in the global financial markets for more than 30 years using quantitative research methods to develop sophisticated trading strategies and is a global private investor with a focus on finance and technology sector opportunities.

 

Media Contact:

KT McGraw

781.879.2395

Your privacy matters

We believe that an individual’s meaningful control over their own data is as valuable as the data itself. That’s why we are committed to protecting privacy at every turn.
We always:
  • Provide transparency about the information we collect and why we collect it
  • Comply with all applicable privacy rules and regulations
  • Delete personal data from our servers if an individual opts out
We never:
  • Sell data to third parties
  • Share data with third parties besides the primary, explicitly authorized institution
  • Collect data besides what is disclosed
  • Keep personal data for individuals who have opted out

We speak legalese only when we have to, but we do our best to keep it human. Provided below are the full versions of our Privacy Policy and Terms of Service. If you have any questions, don’t hesitate to contact us for clarification.

George Pace

VP Business Development, Payer Markets

George has over two decades of consulting, business development and client success experience in health care, working with both providers and payers to address their most pressing challenges. The bulk of his healthcare career was with The Advisory Board, Optum, Premier and Verisk Health, with a focus on risk mitigation, value-based care and population health management. He is deeply passionate about helping healthcare organizations do their best for their patients and beneficiaries. 

When he’s not working, you will find him playing guitar, riding his bike or spending time with family, friends, and his dog Luna.  

Summer Kramer
VP Clinical Programs

Summer is a clinical pharmacist with over 15 years of experience in the healthcare industry, including hospitals, payors, and start-ups. Summer has focused her career on clinical program development and healthcare analytics with a constant drive to improve patient outcomes.

Residing in the pacific northwest, Summer enjoys hiking, camping, sailing, and traveling. She received her PharmD from the University of New Mexico, College of Pharmacy.  

Laura Clote
VP Provider Operations

Laura has over 14 years of experience in value-based care operations, working closely with and for health care systems and start-ups to drive operational change.  Outside of work, she loves to spend time in the great Oregon outdoors with her Bernese Mountain Dog, Bam Bam.  She received an MPH in Health Care Management from Harvard School of Public Health.

Karan (Kay) Mansukhani
VP Business Development

Kay has a decade of experience in population health analytics.  Starting his career in Maryland’s state-designated HIE – CRISP,  he was entrusted to set up the infrastructure and data elements needed by health system to achieve CMMIs Triple Aim. Kay is a trained epidemiologist who has a passion for preventive medicine, psychology, and anthropology. Kay enjoys spending lazy days with his wife Sonal, and son Avtar on the beach.  Kay also enjoys listening to podcasts, playing the guitar and badminton. He received his joint MPH MBA from Johns Hopkins University.

Kevin Sampson
VP Finance

Kevin is a CPA with 25 years of executive and managerial experience in accounting, corporate finance, and operations in a variety of industries including medical device, biotechnology, and pharmaceuticals.

By listening and connecting with people, Kevin understands that accurate timely information is vital for everyone in the healthcare system. He received a BS in Accounting and an MBA in Finance and Entrepreneurial Studies from Babson College.

Paul Manberg
VP Clinical and Regulatory Affairs

Paul is an innovative, pragmatic leader with over 40 years’ experience in the medical device and pharmaceutical industries. He has directed clinical trial programs and regulatory activities supporting the successful market introduction of numerous impactful products. He spends his leisure time on the Outer Banks of North Carolina, body surfing and fishing. He received a PhD in pharmacology from The University of North Carolina School of Medicine.

Scott Greenwald
Chief Scientist

With over 25 years’ experience in healthcare research and innovation, Scott is an unprecedented leader in his field, focusing on improved care for everyone. He is an author of over 10 US Patents and over 100 peer-reviewed abstracts and manuscripts. While he’s not immersed in research, you’ll find him playing a mean round of mini golf. He received a PhD in Medical Engineering from the Harvard-MIT Division of Health Sciences and Technology (HST).

Josh Gray
VP Analytic Services
Josh has 30 years’ experience in healthcare, including The Advisory Board Company, athenahealth, and Boston Consulting Group. Across his career, he has used a wide range of conventional and unconventional data sources to understand and teach the keys to top performance among the nation’s most innovative health systems and physician groups. Josh enjoys music, hiking, traveling, and watching his daughter take part in synchronized skating competitions. He received an MBA from The Wharton School at the University of Pennsylvania and an undergraduate degree from Brown University.
Carola Endicott
VP Customer Engagement, Marketing

Carola has 30 years’ experience in healthcare, including HMOs, hospitals, and start-ups. Her knowledge and optimistic outlook in operations and leadership, and her passion for making healthcare workers’ lives easier is what drives her devotion to customer engagement. She received an EdM from Harvard University Graduate School of Education.

David Clain
Chief Product Officer
David has vast experience with healthcare customers from his time at The Advisory Board Company and athenahealth. His expertise and passion for statistics, strategy, and innovative analytic insights is unrivaled, as is his devotion to the Duke Blue Devils. Looking for that “aha moment” of positive change is what drives him. He received a BA from Duke University.
Mike Bertrand
VP Product Development

A hard-working go-getter and outdoorsman, Mike has over 30 years of experience in Healthcare IT. Mike is a seasoned product guru with broad experience across the healthcare software spectrum. He received a BS in Computer Science from Westfield State University.

Margie Ahearn
VP HR

Margie has 25 years of experience in HR leadership. An avid boater, Margie has received numerous awards for excellence in HR and is always looking for challenges to grow professionally and personally. She graduated with an MBA from Southern New Hampshire University.

Nassib Chamoun
Founder and CEO and cheerleader-in-chief

Nassib is a data scientist, lover of logistical regression and serial entrepreneur. Outside of work he enjoys hosting and honing his cooking skills – specializing in Middle Eastern and outdoor feasts. He received an MS from Boston University.

Phil Devlin
COO

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.

What guides our culture

1

We are driven to make a profound impact on US healthcare

2

We operate in the best interests of patients and those who serve them

3

We understand and protect patient privacy and health information security

4

We use data science to enhance, but never replace clinical expertise and judgment

5

We are committed to continuous learning and improvement

6

We bring rigor, discipline, and reliability to our work

7

We start with kindness, assuming good intent in others

8

We are committed to building a diverse, inclusive team where all employees feel welcomed and appreciated

9

We are committed to the well-being of our employees and their families

Phil Devlin
COO

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.